1 / 9

Clinical Trial Management System Market share valued $2.4bn by 2024

Get more details @ http://bit.ly/2ltDwaH <br>Key industry players in Clinical Trial Management System Market include Oracle Corporation, MedNet Solutions, BioClinica, Bio-Optronics, and Medidata solutions.

jueekate
Download Presentation

Clinical Trial Management System Market share valued $2.4bn by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Trial Management System Market share worth $2bn by 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. KeyInsights from Clinical Trial Management System Market: • Rapid economic progress coupled with favorable government regulations for drug approvals will push CTMS market size in emerging economies. • High investments in clinical research activities are expected to boost the demand for clinical trial management systems (CTMS) across pharmaceuticals & biopharmaceuticals firms, clinical research organizations, and healthcare sectors. • CTMS market is segmented into site based clinical trial management system and enterprise based clinical trial management system. • Enterprise based industry, which accounted for more than 70% of the total revenue in 2015, is anticipated to grow considerably over the coming timeframe, driven by its ability to provide specialized services. • Site based CTMS is projected to contribute considerably towards the global industry share over the coming seven years.

  3. Continued... • Pharmaceuticals & Biopharmaceuticals application, which dominated the end-use application landscape in 2015, is forecast to hit USD 1.4 billion by 2024. • Tremendous efforts by market players to manufacture new medicines for treating chronic ailments is expected to boost the revenue. • CTMS industry size in clinical research organizations is expected to grow at a rate of 14% over 2016-2024, driven by rise in clinical trial outsourcing activities along with high investments in R&D for clinical research business. • China CTMS industry revenue is forecast to produce more than USD 270 million by 2024. • Key industry players include eClinForce Incorporation, MedNet Solutions Incorporation, Forte Research Systems Incorporation, Medidata solutions, Bio-Optronics Incorporation, PAREXEL International Corporation, Merge Healthcare Incorporation, VEEVA Systems, Oracle Corporation, and BioClinica Company.

  4. Europe Clinical Trial Management System Market share, by component, 2012-2024 (USD Million)

  5. Browse Full Market Research Report On Clinical Trial Management System Market @ http://bit.ly/2mErWKQ Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/1155https://www.gminsights.com/request-sample/detail/49

  6. Table of Content: Chapter 1. Methodology and Scope 1.1. Research Methodology 1.1.1. Initial data exploration 1.1.2. Statistical model and forecast 1.1.3. Industry insights and validation 1.1.4. Research scope and assumptions 1.2. Data Sources 1.2.1. Primary sources 1.2.2. Secondary sources Chapter 2. Executive Summary 2.1. Clinical Trial Management System industry 3600 synopsis, 2012 – 2024 2.1.1. Business trends 2.1.2. Regional trends 2.1.3. Application trends

  7. Continued... • Chapter 3. Clinical Trial Management System Industry Insights • 3.1. Industry segmentation • 3.2. Industry size and forecast, 2012 – 2024 • 3.3. Industry impact forces • 3.3.1. Growth drivers • 3.3.1.1. Outsourcing of clinical trails • 3.3.1.2. Enhanced R&D expenditure of life science and clinical research industries • 3.3.1.3. Increased number of clinical trials • 3.3.2. Industry pitfalls & challenges • 3.3.2.1. High cost of Clinical Trial Management System • 3.4. Growth potential analysis

  8. Continued... 3.5. Regulatory landscape 3.5.1. U.S. 3.5.2. Europe 3.5.3. China 3.6. Software landscape 3.7. Porter’s analysis 3.8. PESTEL analysis 3.9. Competitive landscape, 2015 3.9.1. Strategy dashboard

  9. Stay In Touch Website: www.gminsights.com Social Media:

More Related